TScan Therapeutics, Inc.

NASDAQ
TCRX
Stock
Yield per half year: -36.73%
Dividend yield: 0%
Sector: Healthcare

Reporting TScan Therapeutics, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.1951 0.0769 0.284 0.106 0.1853 13.33
Выручка, млрд $
0.0011 0.0101 0.0135 0.021 0.0028 0.0028 0.0097 20.55
Чистая прибыль, млрд $
-0.0131 -0.026 -0.0486 -0.0658 -0.0892 -0.1275 -0.1275 -0.0714 37.44
EV, млрд $
-0.0369 -0.0274 -0.1029 0.0018 0.3494 0.2271 0.2271 0.0896 -252.65
EBIT, млрд $
-0.0142 -0.0262 -0.0486 -0.065 -0.0855 -0.1238 -0.1238 -0.0698 36.42
EBITDA, млрд $
-0.0137 -0.025 -0.0453 -0.0599 -0.0801 -0.1197 -0.1197 -0.0660 36.78
OIBDA, млрд $
-0.0252 -0.0453 -0.0607 -0.0843 -0.1271 -0.1271 -0.0685 38.21
Баланс стоимость, млрд $
-0.0171 -0.0425 0.1608 0.0994 0.1509 0.241 0.241 0.1219 -241.49
FCF, млрд $
-0.0138 -0.0073 -0.0586 -0.0707 -0.0645 -0.1146 -0.1146 -0.0631 73.45
Операционный денежный поток, млрд $
-0.0125 -0.003 -0.0487 -0.0665 -0.0614 -0.1108 -0.1108 -0.0581 105.82
Операционная прибыль, млрд $
-0.0142 -0.0262 -0.0486 -0.0666 -0.0935 -0.1348 -0.1348 -0.0739 38.76
Операционные расходы, млрд $
0.0142 0.0273 0.0588 0.0802 0.1145 0.1376 0.1376 0.0837 38.19
CAPEX, млрд $
0.0012 0.0042 0.0099 0.0042 0.0031 0.0038 0.0038 0.0050 -1.98


Balance sheet

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0418 0.0348 0.1614 0.12 0.1334 0.1787 0.1787 0.1257 38.71
Short Term Investments $
0.0587 0.1114 0.1114 0.0851 37.76
Total Current Assets $
0.0424 0.0364 0.1657 0.12 0.1942 0.2927 0.2927 0.1618 51.73
Чистые активы, млрд $
0.0424 0.0364 0.1657 0.0101 0.0956 0.0101 0.0700 17.66
Активы, млрд $
0.0494 0.0497 0.1881 0.1991 0.2721 0.3711 0.3711 0.2160 49.50
Short Term Debt $
0.000443 0.0014 0.0017 0.0074 0.0066 0.0046 0.0046 0.0043 26.86
Long Term Debt $
0.0293 0.0267 0.0321 0.0321 0.0294 3.09
Задолженность, млрд $
0.0665 0.0922 0.0273 0.0997 0.1213 0.1301 0.1301 0.0941 7.13
Чистый долг, млрд $
-0.0369 -0.0274 -0.1554 -0.034 -0.0409 -0.1134 -0.1134 -0.0742 32.85
Долг, млрд $
0.0049 0.0074 0.006 0.086 0.0924 0.0653 0.0653 0.0514 54.57
Interest income $
0.000552 0.000106 0.0000 0.0016 0.0063 0.0021 83.80
Расходы на обслуживание долга $
0.0000 0.0012 0.0038 0.0037 0.0037 0.0029 45.55
Чист. проц. доходы, млрд $
0.000552 0.000106 0.0000 0.0016 0.0063 0.0063 0.0021 83.80
Амортизация, млрд $
0.000519 0.0012 0.0033 0.0051 0.0054 0.0041 0.0041 0.0038 27.86
Себестоимость, млрд $
0.000519 0.0206 0.0033 0.0051 0.0882 0.0054 0.0235 179.29


Share

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.5475 -1.09 -4.17 -2.74 -1.36 -1.14 -1.14 -2.1000 0.90
Цена акции ао 8.16 1.55 5.83 3.04 1.55 1.55 4.03 -28.27
Число акций ао, млн 23.94 23.94 11.66 24.05 65.6 111.99 111.99 47.45 36.15
FCF/акцию -0.5752 -0.3033 -5.03 -2.94 -0.9833 -1.02 -1.02 -2.0553 27.45


Efficiency

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 76.47 87.32 -82.17 -50.58 -71.29 -65.08 -65.08 17.60 -36.3600 -194.29
ROA, % -26.54 -52.5 -40.87 -33.99 -37.87 -39.64 -39.64 5.71 -40.9740 -5.46
ROS, % -2398.25 -479.49 -486.19 -423.86 -4527.66 -4527.66 -4527.66 13.36 -2088.9720 56.68
ROCE, % -30.24 -81.24 -29.17 -35.78 -35.27 -36.95 -51.39 -51.39 29.73 -37.7120 11.99
Ebit margin, % -2417.79 -479.49 -480.57 -406 -4397.94 -4397.94 -4397.94 18.53 -2032.3880 55.77
Рентаб EBITDA, % -2304.42 -446.83 -442.62 -380.53 -4252.06 -4252.06 -4252.06 26.10 -1954.8200 56.92
Чистая рентаб, % -2398.25 -479.33 -486.19 -423.86 -4527.66 -4527.66 13.36 -1663.0580 13.55
Operation Margin, % -2417.79 -479.65 -492.32 -444 -4787.68 -4787.68 -4787.68 16.64 -2198.2660 58.43
Доходность FCF, % -30.05 -91.96 -22.71 -48.2400 -8.91


Coefficients

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-4.01 -1.17 -3.18 69.12 -2.7867 -7.44
P/BV
0.3264 0.3604 2.59 1.41 1.41 8.87 1.17 44.17
P/S
5.18 2.65 18.54 120.9 120.9 8.05 36.82 119.80
P/FCF
-3.33 -1.09 -1.5 -1.64 -0.9246 -0.9246 8.97 -1.6969 -22.61
E/P
-0.2492 -0.8556 -0.3141 -0.8417 -1.2 -1.2 0.03 -0.6921 36.94
EV/EBIT
2.6 1.04 0.8203 -0.0275 -4.09 -1.83 -1.83 -1.83 88.11 -1.3914 -217.41
EV/EBITDA
2.69 1.09 2.27 -0.0299 -4.36 -1.9 -1.9 53.63 -0.5860 -211.75
EV/S
-25.21 -3.93 0.1322 16.6 80.64 80.64 80.64 8.36 34.82 -282.99
EV/FCF
2.68 3.77 0.6805 -0.0253 -5.42 -1.98 -1.98 -1.98 21.77 -1.7450 -223.81
Debt/EBITDA
-0.3569 -0.2973 -0.1334 -1.44 -1.15 -0.5454 -0.5454 -0.5454 2.61 -0.7628 32.53
Netdebt/Ebitda
2.69 1.09 3.43 0.5683 0.5109 0.9469 0.9469 0.9469 0.49 1.28 -22.70
Debt/Ratio
0.099 0.1495 0.0321 0.4319 0.3396 0.176 0.176 0.176 0.24 0.2311 40.54
Debt/Equity
-0.2852 -0.1751 0.0376 0.8647 0.6127 0.271 0.5401 0.5401 2.82 0.4652 70.40
Debt/Net Income
-0.3729 -0.2857 -0.1243 -1.31 -1.04 -0.5122 -0.5122 -0.5122 10.75 -0.6997 32.74
PEG
0 0 -67.37
Бета
13.38 -3.46 -0.2195 -0.2195 0.01 3.23 -125.41
Индекс Альтмана
0.0962 -1.19 -0.1612 -0.2283 -0.4064 -0.4064 12.59 -0.3779 -233.40


Dividends

IFRS
Reporting Annual Quarterly
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.71
Дивиденды / прибыль, %
0 155.02


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023 2024 LTM CAGR 5
CAPEX/Выручка, %
390.6 98.03 31.22 14.95 135.83 135.83 -19.04
Персонал, чел
136 154 6.41